@MassBio
Account based inUnited States
About this account
- Account based in
- United States
- Connected via
- United States App Store
Account-level information from X, not a live location or the device used for a specific post.
MassBio is committed to advancing MA's leadership in the life sciences to grow the industry, add value to the healthcare system & improve patient lives.
Cambridge, MA USA
Joined June 2009
- Tweets27.2K
- Following1.8K
- Followers51.8K
- Likes4.3K
Changes in Washington are having real implications for how life sciences companies raise capital, advance new therapies, and fund research. Join the conversation on October 15 at #AlignSummit26 - massbio.org/events/align-sum…
MassBio and the @MAWomensCaucus will co-host on October 1 the 2026 Women's Health Symposium - open this year to all #MassBioMembers.
Register to hear from the following speakers on how they are turning women's pancreatic cancer visibility into action: massbio.org/events/womens-he…
What shapes the patient journey? From early awareness and diagnosis to treatment, transplantation, and life beyond, this year's #PatientAdvocacySummit26 on 11/12 will explore the real-world experiences & personal stories of those impacted by disease: massbio.org/events/patient-a…
The 55 companies presenting at #AlignSummit26 are officially live!
With the event just a few weeks away on 10/15, meet the pre-seed to Series B companies presenting at this year’s Summit, explore the agenda, and register to attend: massbio.org/events/align-sum…
We’re excited to announce the 10 startups in the Drive Fall 2026 Cohorts with MassBio and @SCBiotech - learn more about them here: massbio.org/drive/ and see them in action at Align Summit.
MassBio retweeted
My convo with @MassBio CEO @KendalleOC on industry jobs shrinking last year, China's ascension and NIH grants.
endpoints.news/massbio-repor…
MassBio retweeted
𝐑𝐚𝐫𝐞 𝐃𝐢𝐬𝐞𝐚𝐬𝐞 𝐃𝐫𝐮𝐠 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭: Two fathers of children with rare diseases talk about starting biotech companies to try to create new therapies for their family members and others. @MassBio @Solid_Bio @TevardB
Full video: biotechtv.com/post/rare-dise…
MassBio retweeted
In Massachusetts, Latest Annual Snapshot Shows a Tale of Two Biopharmas
#Lifesciences industry group @MassBio finds that growth-stage companies based in the Bay State are reaping the fruits of growth in VC, IPO, and M&A activity
#GENEdge #biopharma
hubs.li/Q04vnpn00
MassBio retweeted
𝐁𝐫𝐢𝐠𝐡𝐭 𝐌𝐢𝐧𝐝𝐬: @MassBio's 2026 Industry Snapshot shows a biotech sector that has been accelerating this year, but warning signs about early stage company building and investments should be given close attention.
Full video: biotechtv.com/post/massbio-2…
Today's IPO class was funded five to eight years ago. Our 2026 Industry Snapshot has the full picture, including new sections on licensing, clinical trials, and China's rise.
Read the report: massbio.org/industry-reports…
Where is pharma looking for its next opportunity?
At #AlignSummit26 on 10/15, get the insights that could help shape your next investment, partnership, or strategic move.
Register now: massbio.org/events/align-sum…
Summer Savings Week showcased the many ways MassBioEdge helps members save, connect, and get more from their membership.
Take a look back at the highlights and learn how members can keep saving year-round. Read more: massbio.org/news/recent-news…
Thank you to all of our speakers, co-chairs, #MassBioMember attendees, and sponsor Tobin Scientific at today's Facilities and Lab Operations Roundtable.
Learn more and sign up for our next Executive Roundtables: massbio.org/events/
Caroline Allen, Head of Patient Advocacy at ITF Therapeutics shares her experience with the Duchenne community at Camp Promise. Read her guest blog: massbio.org/news/recent-news…
#MassBioMembers #PatientDriven #PatientAdvocacy
Biotech is gaining momentum again. The companies that stand out are those with differentiated science, a clear value proposition, and the right connections.
If you're a funder looking to discover what's next in biotech, join us on Oct 15 at Align Summit: massbio.org/events/align-sum…
Innovation should not be limited by the cost of the tools required to create it. So how can the industry accelerate scientific innovation while lowering unnecessary costs throughout the research and manufacturing lifecycle? Read more in this member blog: massbio.org/news/recent-news…
Last night was our annual Summer Mixer🌞
It's always great seeing our community for an evening connecting with colleagues and enjoying some fun!
📷View event photos: flic.kr/s/aHBqjD1q2F
🗓️View upcoming events: massbio.org/events/
This month's @BiotechTV U.S. Science Summit brought together biotechnology leaders, researchers, investors and science communicators to discuss the opportunities and challenges shaping the future of the industry. Read more in our new blog: massbio.org/news/recent-news…
